Azitra (AZTR) vs Traws Pharma (TRAW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Azitra is the larger company by market cap ($7.9 million vs $6.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZTR | TRAW |
|---|---|---|
| Share price | $0.1299 | $0.4452 |
| Market cap | $7.87M | $6.84M |
| 1-day change | -1.59% | -7.31% |
| EPS (TTM) | $-0.28 | $-1.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.09 | $3.27 |
| 52-week low | $0.10 | $0.43 |
| Distance from 52-week high | -88.08% | -86.39% |
| Analyst consensus | buy | none |
| Avg. price target upside | +415.78% | +124.62% |
| Average volume | 1.68M | 569.02K |
| Shares outstanding | 60.60M | 15.37M |
| Employees | 13 | 4 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Azitra
AZTR stock →Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
About Traws Pharma
TRAW stock →Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are designed to address treatment resistance, such as TRX01 (Ratutrelvir), an inhibitor in development for the treatment of COVID-19; and Tivoxavir marboxil, an endonuclease inhibitor in development for the treatment of bird flu and seasonal influenza.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
AZTR vs TRAW FAQ
Which is bigger, Azitra or Traws Pharma?
Azitra (AZTR) is larger, with a market capitalization of $7.87M compared with $6.84M for Traws Pharma (TRAW).
Are Azitra and Traws Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.